- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
-0.03| Last Update: 06/18/13 - 4:00 PM EDT |
| Volume: 396,862 |
| YTD Performance: -21.18% |
| Open: $18.66 |
| Previous Close: $18.60 |
| 52 Week Range: $16.37 - $30.59 |
| Oustanding Shares: 54,540,255 |
| Market Cap: 1,014,994,146 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.00 | $-0.02 | $0.05 | $0.28 |
| Number of Analysts | 7 | 7 | 8 | 7 |
| High Estimate | $0.02 | $0.00 | $0.09 | $0.46 |
| Low Estimate | $-0.02 | $-0.06 | $0.04 | $0.06 |
| Prior Year | $0.06 | $0.04 | $0.15 | $0.05 |
| Growth Rate (Year over Year) | -107.14% | -160.71% | -67.50% | 468.50% |
Volcano downgraded at William BlairVOLC was downgraded to Market Perform, William Blair said. Company has poor earnings visibility.
Volcano downgraded at GoldmanVOLC was downgraded from Buy to Neutral, Goldman Sachs said. Company was also cut from the Conviction List. Base business will likely continue to face pressure. $25 price target.
Volcano downgraded at Credit SuisseVOLC was downgraded from Outperform to Neutral, Credit Suisse said. $32 price target. Estimates also cut, as the company sold new debt and may make new acquisitions.
Volcano Corp downgraded at JMPVOLC was downgraded to Market Underperform from Market Perform, JMP Securities said. $20 price target. Longer term fundamentals of PCI market unlikely to reverse themselves.
Volcano rated new Outperform at Credit SuisseVOLC was initiated with an Outperform rating, Credit Suisse said. $36 price target. Company has a solid growth profile and is a potential takeover target.
Volcano added to Conviction Buy List at GoldmanVOLC was placed on the Conviction Buy list, according to Goldman Sachs. Estimates also boosted, given solid penetration of FM technology. $36 price target.
Volcano Corp. upgraded at JefferiesShares of VOLC upgraded to Buy from Hold, Jefferies said. $37 price target. Rare story in medical devices that checks all the boxes.
Volcano upgraded at GoldmanVOLC was upgraded from Neutral to Buy, Goldman Sachs said. $36 price target. FFR business should drive growth over the coming quarters.
Volcano downgraded at Feltl
Volcano estimates, target upped at GoldmanVOLC estimates were boosted through 2015, Goldman Sachs said. Company is gaining market share. Neutral rating and new $28 price target.